You get your cholesterol numbers back. Your doctor says your LDL cholesterol is high. She probably at least mentions a statin. Maybe she tells you to cut back on fat and eggs. You leave the appointment with a number, maybe a prescription, a vague sense of concern, and confusion about what is happening in your body, since you haven’t changed anything about your lifestyle.

This is an experience many women in the menopause hormonal transition have, and it is a problem. Cholesterol numbers are not self-explanatory, and the standard conversation around them is often incomplete. Knowing what each marker in the lipid panel actually measures, how they relate to one another, and what causes them to change in midlife gives you the foundation to ask better questions and make more informed decisions.

That is what this post is intended to do for you.

What is Cholesterol?

Cholesterol is a waxy, fat-like substance found in every cell in your body. Although we almost only ever talk about it as it relates to bloodwork, it is essential for life. Your body uses it to:

• Build and maintain cell membranes,
• Produce hormones, including estrogen, progesterone, testosterone, and cortisol,
• Create vitamin D,
• Make bile acids, which are necessary for digesting and absorbing dietary fats,
• Support signaling between cells, and
• Enable nerve function.

Your liver produces most of the cholesterol your body needs. The rest comes from food. Because cholesterol is a fat, it cannot dissolve in water, and therefore, cannot travel through the bloodstream on its own. Instead, the liver packages cholesterol into protein-wrapped carriers called lipoproteins, the best known of which is LDL. These lipoproteins shuttle cholesterol to and from cells throughout the body.

Cholesterol is not inherently dangerous. The problems arise when the balance and quality of these lipoprotein carriers is disrupted, a distinction that matters far more than most cholesterol conversations acknowledge.

What does a Lipid Panel Measure?

A standard lipid panel measures three values: total cholesterol, HDL cholesterol, and triglycerides. LDL cholesterol is calculated, as is non-HDL cholesterol, a number increasingly recognized as important to cardiovascular health.

LDL Cholesterol (Low-Density Lipoprotein)

LDL is the most well-known lipoprotein that carries cholesterol from the liver to cells throughout the body. It has long been labeled “bad cholesterol”, and high LDL cholesterol levels are consistently associated with increased cardiovascular risk in large population studies.

But the full picture is more nuanced than that framing suggests. Research shows that it is primarily oxidized LDL (i.e., LDL that has been damaged by oxidative stress) that drives the inflammatory cascade leading to plaque formation in artery walls and atherosclerosis. The amount of native LDL cholesterol alone does not tell the whole story. Rather, the state of your whole vascular environment, specifically the level of inflammation and endothelial function (meaning the health of your blood vessel lining), matters just as much as the LDL number itself.

One thing worth knowing before we go further: the LDL number on your lab report is almost always calculated, not directly measured. Most labs use the Friedewald or the Martin/Hopkins equations, which estimate LDL from total cholesterol, HDL, and triglycerides. This calculation becomes less accurate when triglycerides are elevated or when LDL is very low. A directly measured LDL (sometimes called LDL-direct or direct LDL) is available but rarely ordered as part of routine bloodwork.

Even though it is usually an estimate, LDL levels still matter, and elevated LDL cholesterol is a risk factor worth taking seriously. But treating it as the single villain or the lone route to eradicate heart disease oversimplifies a complex process, and it is one reason why many people with high LDL never develop cardiovascular disease and some with normal or low LDL do.

HDL Cholesterol (High-Density Lipoprotein)

HDL is often called the “good cholesterol” because it helps transport cholesterol away from the arteries and back to the liver for breakdown and elimination. Higher HDL levels are generally associated with lower cardiovascular risk.

HDL’s role is more complex than a simple cleanup crew, though. It also exchanges cholesterol for triglycerides with intermediate-density lipoproteins (IDL) and very low-density lipoproteins (VLDL), playing an active role in overall lipoprotein metabolism. How well HDL functions, not just how much HDL cholesterol exists, is increasingly recognized as clinically meaningful.

Triglycerides

Triglycerides are the primary form of fat found in both food and the body. When you consume more energy than your body needs, the excess (whether it’s excess fat, protein, carbohydrates, or alcohol) is converted into triglycerides and stored in fat cells.

Elevated triglycerides combined with low HDL or high LDL significantly increase cardiovascular risk. High triglycerides are also associated with insulin resistance, which is particularly relevant for midlife women.

Total Cholesterol

Total cholesterol is the sum of all cholesterol in the lipoproteins, including HDL and LDL, circulating in the blood. It is a useful screening number, but its application is limited as a standalone marker. Two people can have the same total cholesterol numbers with very different risk profiles depending on the breakdown between LDL and HDL.

Non-HDL Cholesterol

Non-HDL cholesterol is calculated by subtracting HDL from total cholesterol. It estimates all the cholesterol in the purported atherogenic (plaque-promoting) lipoproteins in the blood, not just LDL. The 2026 ACC/AHA Guideline on the Management of Dyslipidemia now recognizes LDL cholesterol and non-HDL cholesterol as treatment targets, reflecting growing evidence that it contributes to a more complete assessment of cardiovascular risk. It is considered a particularly useful number when triglycerides are high.

Cholesterol Levels by Age Chart

The following cholesterol levels by age charts reflect standard clinical reference ranges from the U.S. National Library of Medicine and AHA/ACC guidelines. These are the ranges you are likely to see on your lab report.

Normal triglyceride and cholesterol levels in adulthood (20 – 79 years):

LIPID PANEL MARKER	ACCEPTABLE (mg/dL)	BORDERLINE (md/dL)	ABNORMAL (mg/dL)
Total cholesterol	< 200	Not specified	≥ 200
Triglycerides	< 150	150 – 199	High: 200 – 4991 Very high: ≥ 500
HDL cholesterol (men)	> 60	40 – 59	< 40
HDL cholesterol (women)	> 60	50 – 59	< 50
LDL cholesterol2	< 100	101 – 159	High: 160 – 189 Very high: ≥ 190
Non-HDL cholesterol	< 130	Not specified	≥ 130

1: Although ≥ 500 mg/dL is considered very high through most of the AHA/ACC guidelines, there is a recommendation to ensure the triglycerides were measured in a fasting state if ≥ 400 mg/dL before treatment decisions are made.
2: The LDL cholesterol target of < 100 mg/dL is for individuals who are at borderline or moderate risk of cardiovascular disease. For individuals at low (< 3%) 10-year estimated risk, LDL cholesterol < 160 mg/dL does not warrant a pharmaceutical intervention, according to the guidelines. Additional targets are listed below in the LDL treatment targets by cardiovascular risk level table.

 

Normal triglyceride and cholesterol levels in childhood (< 20 years):

LIPID PANEL MARKER	ACCEPTABLE (mg/dL)	BORDERLINE (md/dL)	ABNORMAL (mg/dL)
Total cholesterol	< 170	170 – 199	≥ 200
Triglycerides (0-9 yrs)	< 75	75 – 99	≥ 100
Triglycerides (10-19 yrs)	< 90	90 – 129	≥ 130
HDL cholesterol	> 45	40 – 45	< 40
LDL cholesterol	< 110	110 – 129	≥ 130
Non-HDL cholesterol	< 120	120 – 144	≥ 145

 

LDL treatment targets by cardiovascular risk level (2026 ACC/AHA Guideline on the Management of Dyslipidemia):

CARDIOVASCULAR RISK LEVEL1	LDL TARGET (mg/dL)	NON-HDL TARGET (mg/dL)
Borderline or intermediate risk	< 100	< 130
High risk	< 70	< 100
Very high risk	< 55	< 85

1: Risk level is assessed by presence of conditions such as family history, diabetes, existing cardiovascular disease (including hypertension), subclinical atherosclerosis, and hypertriglyceridemia.

 

The Problem with Standard Ranges

There is an important distinction between a “normal” range and an “optimal” range, and your lab report gives you only the former.

Standard reference ranges are derived from population averages. They tell you where most people fall, not necessarily where you want to be for long-term health. As well, a result flagged as normal on your bloodwork may still be trending in the “wrong” direction, particularly if you are in perimenopause or postmenopause, a life stage that can cause metabolic changes that put us at greater risk of heart disease.

This is why we need more informed and complete conversations with our healthcare providers, and ideally a conversation that goes beyond a single cholesterol number.

What Happens to Cholesterol in Perimenopause and Postmenopause?

If your cholesterol numbers have shifted in your 40s or 50s without a significant change in your diet or lifestyle, you are witnessing some of the physiological changes that your body is undertaking during this menopause transition.

Estrogen plays an active role in lipid metabolism, supporting the liver’s ability to clear LDL from the bloodstream and maintain a favorable lipoprotein balance. As estrogen declines during the midlife hormone transition, that regulatory support diminishes.

Research shows that this shift is most pronounced for women during late perimenopause and early postmenopause, rather than being a result of aging in general. On average, LDL rises by 30–50% during this transition, which is a significant shift. Women who had consistently favorable lipid profiles in their 30s and early 40s may see meaningful changes in their late 40s and 50s, and this change is driven primarily by hormonal shifts.

This matters because cardiovascular disease risk in women increases significantly after menopause. At the same time, our cholesterol numbers and even the entire lipid panel don’t tell us the whole story about our risk. And they certainly don’t remind us that we have power over how the story unfolds.

What is Missing from the Standard Conversation?

Your standard lipid panel gives you a starting point. But there is a growing body of evidence, now being acknowledged in mainstream cardiology, that LDL alone is not the complete picture of cardiovascular risk.

The functional and integrative medicine community has used ApoB as a piece of the risk assessment for years. Now mainstream cardiology is catching up: the 2026 ACC/AHA Dyslipidemia Guideline formally elevated ApoB’s clinical standing, recommending it as a useful additional measure, particularly when standard lipid goals have been met but residual risk remains.

And yet, even ApoB is not the complete picture. The state of your vascular environment, including inflammation levels, endothelial function, insulin resistance, oxidative stress, and additional markers beyond what is included in a standard lipid panel, all contribute to cardiovascular risk in ways that no single number captures.

Understanding your cholesterol numbers is a starting point. Knowing what they do and do not tell you is what allows you to have a more complete conversation about your cardiovascular health and to develop the most appropriate plan to maintain your wellness for decades to come.

Frequently Asked Questions

What is cholesterol?

Cholesterol is a waxy, fat-like substance found in every cell in the body. It is essential for building cell membranes, producing hormones (including estrogen and cortisol), synthesizing vitamin D, making bile acids for fat digestion, supporting intracellular signaling, and enabling nerve function. Your liver produces most of the cholesterol your body needs; the rest comes from food.

What is bad cholesterol?

“Bad cholesterol” refers to LDL (low-density lipoprotein), the lipoprotein that carries cholesterol from the liver to cells throughout the body. High LDL levels are associated with increased cardiovascular risk, though the relationship is more nuanced than the “bad” label suggests. The body needs LDL cholesterol to survive. And, it is primarily oxidized LDL (i.e., LDL damaged by inflammation and oxidative stress) that drives plaque formation in artery walls. LDL levels matter, but they are one part of a more complex picture.

What is HDL cholesterol?

HDL (high-density lipoprotein) is often called “good” cholesterol because it transports cholesterol away from the arteries and back to the liver for breakdown. Higher HDL levels are generally associated with lower cardiovascular risk. HDL also plays a role in overall lipoprotein metabolism, exchanging cholesterol with other lipoprotein particles including VLDL and IDL.

What are normal cholesterol levels?

For adults 20 and older, standard clinical guidelines define desirable total cholesterol as below 200 mg/dL, LDL below 100 mg/dL, HDL at or above 60 mg/dL, and triglycerides below 150 mg/dL. However, LDL targets are increasingly personalized based on overall cardiovascular risk level rather than a single cutoff. See the cholesterol levels by age charts above for a full breakdown. Note that “normal” on a lab report reflects population averages, not necessarily optimal ranges for long-term health.

What is the LDL cholesterol range?

LDL is classified as follows in standard guidelines: below 100 mg/dL is optimal; 100–129 mg/dL is near optimal; 130–159 mg/dL is borderline high; 160 – 189 mg/dL is high; and 190 mg/dL and above is very high. The 2026 ACC/AHA guideline also sets individualized LDL targets based on cardiovascular risk level, ranging from below 100 mg/dL for those at borderline or intermediate risk to below 55 mg/dL for those at very high risk.

What is the HDL cholesterol normal range?

For women, an HDL level at or above 60 mg/dL is considered desirable. Levels between 50 and 59 mg/dL are considered borderline, and below 50 mg/dL is low. Higher HDL is generally considered protective, though HDL function matters alongside HDL quantity. Plus, research has shown that too high HDL levels can also contribute to unwanted cardiovascular outcomes.

How do you calculate total cholesterol?

Total cholesterol is the sum of all the lipids in the blood: LDL + HDL + 20% of your triglyceride level (which accounts for VLDL cholesterol). Your lab will calculate this for you from your cholesterol numbers and triglycerides in the lipid panel results. A simpler calculation used for non-HDL cholesterol is: total cholesterol minus HDL.

Does not fasting affect your cholesterol test?

For most people, fasting is not required for a standard lipid panel. The 2026 ACC/AHA guideline states that both fasting and non-fasting samples are acceptable. Non-fasting triglycerides can increase by as much as 120 mg/dL, when there is an adverse triglyceride response after eating. However, if your triglycerides are very elevated on a lipid panel which was done in a non-fasting state, your doctor will likely request a fasting sample for more accurate results.

Conclusion

Your cholesterol numbers are information, not a verdict. Understanding what each lipid panel marker measures, how they relate to one another, what shifts in midlife and why, and what the standard panel does not capture gives you a more complete foundation for protecting your cardiovascular health.

Fortunately, the conversation around cholesterol is evolving. Even mainstream cardiology is moving beyond total cholesterol and LDL toward a more nuanced picture that includes additional markers, inflammation, and vascular health. Integrative and functional medicine has been working with this broader framework for years.

If you want to understand your numbers more fully and learn what the research actually says about managing cardiovascular health in midlife, I am developing a course specifically for women on exactly this topic.

---

Join the waitlist: Lower Your Cholesterol Naturally: A Complete Guide for Women in Perimenopause and Postmenopause 

https://offers.feedyourintention.com/cholesterol-course-waitlist

---

Photo by National Cancer Institute on Unsplash.

Sources:

Babakr AT. Oxidized low-density lipoproteins and their contribution to atherosclerosis. Explor Cardiol. 2025;3:101246. https://doi.org/10.37349/ec.2025.101246

Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;153(17).  https://doi.org/10.1161/CIR.0000000000001423

Epstein E, Ekpo E, Evans D, et al. Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank. Eur J Prev Cardiol. Published online September 1, 2025. doi:10.1093/eurjpc/zwaf554

Feingold KR. Dyslipidemia in patients with diabetes. In Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children. Updated October 31, 2023. Accessed May 5, 2026. https://www.endotext.org/chapter/dyslipidemia-in-patients-with-diabetes/

Jiang H, Zhou Y, Nabavi SM, et al. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Front Cardiovasc Med. 2022;9:925923.  doi:10.3389/fcvm.2022.925923

Keirns BH, Sciarrillo CM, Koemel NA, Emerson SR. Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk. J Nutr Sci. 2021;10:e75. doi:10.1017/jns.2021.73

Ryczkowska K, Adach W, Janikowski K, Banach M, Bielecka-Dabrowa A. Menopause and women’s cardiovascular health: is it really an obvious relationship?. Arch Med Sci. 2022;19(2):458-466. doi:10.5114/aoms/157308

Sehayek D, Cole J, Bjornson E, et al. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. J Clin Lipidology. 2025;19(4):844-859. doi:10.1016/j.jacl.2025.05.024

U.S. National Library of Medicine. Cholesterol Levels: MedlinePlus Medical Test. Accessed May 2026. https://medlineplus.gov/lab-tests/cholesterol-levels/

U.S. National Library of Medicine. Triglycerides Test: MedlinePlus Medical Test. Accessed May 2026. https://medlineplus.gov/lab-tests/triglycerides-test/

van Oortmerssen JAE, Mulder JWCM, Kavousi M, Roeters van Lennep JE. Lipid metabolism in women: A review. Atherosclerosis. 2025;405:119213. doi:10.1016/j.atherosclerosis.2025.119213